Latest

Latest therapeutics News | Page 9

  • Latest therapeutics news stories and updates. What is happening today? All recent therapeutics news and developments. Live coverage and timeline of therapeutics. All you need to know about therapeutics.
The updated WHO Benchmarks for Strengthening Health Emergency Capacities expanded to include public health and social measures (PHSM)
Positive high-level results from Japan Phase III trial of acoramidis in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) showed consistency with global ATTRibute-CM…
Better treatments sooner – Hudson’s new RNAte Platform unveiled
Investing In World-First Tech For Vaccine Development
WHO and MPP announce technology transfer license to enable greater patient access to multiple essential diagnostics
Arovella licences novel CARiNKT cell armouring technology
Structural study points way to better malaria drugs
Chimeric Therapeutics completes placement with shortfall commitments
​​CSIRO launches free program for SMEs innovating in Digital Health and Medical Technology​
Combo treatment improves lung cancer outcomes
Mice without immune cells show no SARS-CoV-2 symptoms
Second WHO global technical consultation on public health and social measures during health emergencies, November 2023
ISU researcher wins innovation challenge to seek RNA drug targets
Strengthening Fiscal Responsibility Rules
Discovery of drug candidate to potentially tackle ER-positive breast cancer
World-first breakthrough in malaria treatment
La Trobe University and AdAlta collaboration delivers world-first breakthrough in malaria treatment
Genetic study aims to unlock new osteoporosis treatments
Hudson Institute welcomes inflammation specialist as new Centre Head
WHO’s Science Council issues report on mRNA vaccine technology
Prescient announces the results of PTX-100 Phase 1b study in T-cell lymphoma patients
EnGeneIC granted FDA “Fast-Track” Designation for Novel Armed Nanocell Drug Conjugate (ANDC) Pancreatic Cancer Therapeutic
Cynata Therapeutics secures approval for Phase 2 trial in Turkey
Microba Life Sciences announces results of successful Phase IBD trial
Korean regulator approves Amplia Therapeutics’ pancreatic cancer trial
Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune
Microba completes stage one screening for its autoimmune disease program
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
HKUST Scientists Unveil Promising Target for Alzheimer’s Disease Treatment
Opioid and psychotropic dispensing’s on the decline among Australians living with cystic fibrosis
Cracking the code: researchers unravel how mutant protein drives cancer growth
Oral delivery possibility for silica-based C’Dots
EnGeneIC’s breakthrough Armed Nanocell Drug Conjugate (ANDC) treatment shows promising results in Pancreatic cancer patients who have run out of treatment options
Island Pharmaceuticals doses first cohort in ISLA-101 Single Ascending Dose study
The Cell and Gene Catalyst call for change in submission to scope of practice review
Alterity Therapeutics raises $4.8 million in new placement
ASX Hopeful Aegros Appoints Ex-MP As Advisory Committee Chair
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
Funding supports research speciality in WA
Antimicrobial Resistance: Silent Pandemic
Alterity Therapeutics announces presentation of new data for ATH434
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Australian-invented drug technology used for treatment of anxiety disorders significantly reduces stress hormone response: Phase 2a clinical trial results
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Professor Dion Stub announced as Heart Foundations new Chair of its Victorian Advisory Board
WHO updates guidelines on treatments for COVID-19
Boosting beta cells to treat Type 2 diabetes
Australia, US scientists team up on African swine fever vaccine

© 2026 - The National Tribune Australia